This process relates to a pharmaceutical composition of an Na-K- ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition may be used to treat a skin disorder. In another embodiment, the composition may be used to inhibit cardiac fibrosis.
申请公布号
WO2007089688(A2)
申请公布日期
2007.08.09
申请号
WO2007US02365
申请日期
2007.01.30
申请人
THE UNIVERSITY OF TOLEDO;XIE, ZIJIAN;SHAPIRO, JOSEPH, I.